WILMINGTON, N.C., Sept. 29, 2015 /PRNewswire/ -- AAIPharma
Services Corp. / Cambridge Major Laboratories, Inc. (AAI/CML) has
recently expanded its service capabilities to offer two sites as
options for placement of Disinfectant Effectiveness/ Disinfectant
Qualification (DE/DQ) studies. In order to meet a high customer
demand, provide regional support and complement the existing
services from the Edison, NJ,
facility, AAI/CML now offers DE/DQ at its St. Louis, MO facility. These studies
satisfy the requirements of USP <1072> Disinfectants and
Antiseptics and support clients with their needs to comply with
cGMP 21 CFR 211.67, Equipment Cleaning and Maintenance.
The expansion allows AAI/CML to further support sterile and
non-sterile product manufacturers in the development and
qualification of disinfectant programs to prevent microbial
contamination through pharmaceutical ingredients, process water,
packaging components, manufacturing environment, process and
manufacturing equipment.
"We are excited to expand our disinfectant qualification systems
to our St. Louis facility and
provide the kind of robust systems needed to prevent microbial
contamination in the manufacture of pharmaceutical products,"
stated Ted Dolan, Chief Operating
Officer. "This added capability allows us to offer more
options for regional proximity and flexibility for manufacturing
and testing with AAI/CML from both our St. Louis, MO and Edison, NJ sites."
About AAIPharma Services Corp. and Cambridge Major
Laboratories, Inc.
AAIPharma Services Corp. and Cambridge Major Laboratories, Inc.
have joined to form a world-class supplier of comprehensive
pharmaceutical development and manufacturing services. With
seven sites across the globe, our combined capabilities include API
development and manufacturing, solid state chemistry, formulation
development, analytical development and testing services, clinical
and commercial finished dosage form manufacturing (solid dose and
parenteral), packaging, and stability services. The family of
companies is in the portfolio of American Capital, Ltd. (NASDAQ:
ACAS). Contact us for all your drug development and manufacturing
needs at www.aaipharma.com and www.c-mlabs.com.
Logo - http://photos.prnewswire.com/prnh/20150806/256637LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/aaipharma-services-corp--cambridge-major-laboratories-inc-expands-disinfectant-effectivenessqualification-services-in-st-louis-mo-300151125.html
SOURCE AAIPharma, Inc.